Estonian biotechnology company Icosagen has completed a €45 million expansion [...]
MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]
Estonian biotechnology company Icosagen has completed a €45 million expansion [...]
MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotech focused on microbiome-based [...]